Rising disorders, an increase in the need for blood compounds and their protection, technical developments to boost the Apheresis Equipment Market growth

 

Apheresis Equipment Market

The Apheresis Equipment Market is segmented by Product (Devices and Disposables), Apheresis Procedure (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, and Other Apheresis Procedures), Technology (Centrifugation and Membrane Separation), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2023-2030

The global Apheresis Equipment Market is estimated to be valued at reach US$ 2.66 billion in 2022 and is expected to exhibit a CAGR of 10.47 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

An apheresis is a double-red-cell donation, for instance, it splits RBCs and leaves the remaining non-targeted blood or platelets to the volunteer giver. This way clinics can gather twice as many RBCs as they can in an overall plasma donation.

Competitive Landscape:

Key players in the global Apheresis Equipment Market are Asahi Kasei Corporation, Fresenius SE & Co. KGAA B. Braun SE, and Terumo Corporation (Terumo BCT Inc.).

Market Key Drivers:

Rising disorders, an increase in the need for blood compounds and their protection, technical developments in the advancement of new apheresis methods, and a rise in the compensation schemes and investment for apheresis processes is expected to augment the growth of global Apheresis Equipment Market. For instance, in June 2022, by the NHS-MTFM, NHS England in the UK has selected the automated RBCX therapy carried out on the commerce Spectra Optia Apheresis method to cure sickle cell disorder.

The rising product innovations and launches is projected to boost the growth of global Apheresis Equipment Market. For instance, in July 2021, TBCL declared a direct contribution for doctors to ECP processes beside patient. 

Covid-19 Impact Analysis:

The COVID-19 outbreak had a positive impact on the growth of the global Apheresis Equipment Market, due to the severe usage of plasma therapy to cure patients diseased with COVID-19. As per the study reported in the JCA in December 2021, the shortage of supplies, particularly RBC units and apheresis kits, was one main disease with patient therapy in the apheresis services through the COVID-19 epidemic. 

Key Takeaways:

The global Apheresis Equipment Market is anticipated to exhibit a CAGR of 11.3 % during the forecast period due to rising sickle disease. For instance, according to CDC, May 2022 around 100,000, Americans suffered from sickle cell disease. 

Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the global Apheresis Equipment Market due to hematological diseases, kidney diseases and diseases related to blood and neural disease. For instance, as per the Leukemia & Lymphoma Society (LLS) 2021, around every three minutes, an individual in the U.S is analyzed with blood cancer.